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Abstract
Alpha-thalassemia is the most common inherited disorder of hemoglobin synthesis. Genomic deletions involving the alpha-globin 
gene cluster on chromosome 16p13.3 are the most frequent molecular causes of the disease. Although common deletions can 
be detected by a single multiplex gap-PCR, the rare and novel deletions depend on more laborious techniques for their identifica-
tion. The multiplex ligation-dependent probe amplification (MLPA) technique has recently been used for this purpose and was 
successfully used in the present study to detect the molecular alterations responsible for the alpha-thalassemic phenotypes in 
8 unrelated individuals (3 males and 5 females; age, 4 months to 30 years) in whom the molecular basis of the disease could 
not be determined by conventional methods. A total of 44 probe pairs were used for MLPA, covering approximately 800 kb 
from the telomere to the MSLN gene in the 16p13.3 region. Eight deletions were detected. Four of these varied in size from 
240 to 720 kb and affected a large region including the entire alpha-globin gene cluster and its upstream regulatory element 
(alpha-MRE), while the other four varied in size from 0.4 to 100 kb and were limited to a region containing this element. This 
study is the first in Brazil to use the MLPA method to determine the molecular basis of alpha-thalassemia. The variety of rear-
rangements identified highlights the need to investigate all cases presenting microcytosis and hypochromia, but without iron 
deficiency or elevated hemoglobin A2 levels and suggests that these rearrangements may be more frequent in our population 
than previously estimated.
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The human alpha (α)-globin gene cluster is located on 
the distal portion (p13.3-pter) of the short arm of chromo-
some 16 and includes three functional α-like protein coding 
genes (ζ, α2, and α1), two expressed genes with unknown 
function (µ and θ1), and three pseudogenes (ψζ, ψα1, ψρ) 
arranged in the order 5’-ζ-ψζ- µ- ψα1- α2- α1- ψρ- θ1-3’ (1,2). 
The α-globin regulatory elements lie upstream of the start 
of the ζ-globin gene (10 to 50 kb) and consist of four con-
served DnaseI hypersensitive sites (HS-48, HS-40, HS-33, 
and HS-10) that bind erythroid-specific transcription factors 
(3,4). Of these four sites, HS-40 is the only one capable of 
directing high-level expression of the α-globin chains and 
is thus the major regulatory element (α-MRE) (5).
Molecular lesions affecting the α-globin genes or their 
regulatory element (α-MRE) lead to α-thalassemia, an 
inherited hemoglobin (Hb) disorder characterized by a 
reduction in or absence of α-globin chain synthesis. Dele-
tions are the major molecular cause of the disease and 
may affect one or both α-genes in the chromosome (the 
α+ and α0 forms, respectively) (1,6). The clinical pheno-
type of carriers varies according to the number of genes 
affected. Carriers of three functioning globin genes (-α/αα) 
do not present detectable red blood cell abnormalities or 
globin-chain imbalance, while carriers of two functioning 
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α-genes (-α/-α, --/αα) have mild microcytic, hypochromic 
anemia with normal hemoglobin A2 levels. Carriers of only 
one functioning α-gene (--/-α) present moderate to severe 
anemia with markedly unbalanced globin-chain synthesis 
ratios. Failure to inherit any functional α-globin genes (--/--) 
is usually incompatible with life and leads to Hb Bart’s (γ4 
tetramers) hydrops fetalis (1,7). 
Although α-thalassemia is present throughout the world, 
its distribution varies greatly among different populations. 
In Brazil, most of the recognized α-thalassemia mutations 
involve deletions of one α-globin gene (α+-thalassemias), 
although several cases of α0-thalassemias have been re-
ported in the literature (8-12). It has been shown that the 
-α3.7 deletion is the most frequent mutation in the Brazilian 
population, occurring in 20-25% of the black population in 
the Southeastern region of the country (13).
The most common α-thalassemia deletions can be 
detected by a single multiplex gap-PCR [i.e., -α3.7, -α4.2, 
-(α)20.5, --MED, --SEA, --FIL, --THAI] (14). However, there are 
many cases whose iron profile, Hb A2 and Hb F levels are 
normal but whose red blood cells have reduced mean cor-
puscular volume (MCV) and mean corpuscular hemoglobin 
(MCH), hematological alterations that are characteristic 
of defects in hemoglobin synthesis and whose causes 
remain unidentified. Southern blot and/or FISH have been 
employed to determine the cause of these abnormalities; 
however, both techniques are time consuming and labor 
intensive (15).
Multiplex ligation-dependent probe amplification (MLPA) 
is a simple technique that is suitable for rapid quantita-
tive analysis and allows the detection of any deletions or 
duplications in the screened regions. More recently, it has 
been used to study large alterations in globin genes (15). In 
the present study, we used this technique to determine the 
molecular basis of α-thalassemic phenotypes in 8 unrelated 
individuals, 5 of whom had Hb H disease. 
Patients and Methods
Patients
Eight patients of different ethnic backgrounds suspected 
of having hemoglobinopathies were referred to the UNI-
CAMP Hospital, Campinas, in Southeastern Brazil, for he-
matological and DNA analysis. Three of them were selected 
because, although their iron status was normal, they had 
a thalassemia phenotype (MCV < 70 fl, MCH < 25 pg) and 
structurally intact α-globin genes. The other patients had Hb 
H disease, for which it had not been possible to determine 
the molecular basis as analysis revealed only one mutation 
(-α3.7 deletion). Family analysis was only possible for some 
patients because samples were not available for all family 
members. Demographic, hematological and molecular data 
of patients and relatives are summarized in Table 1. 
Red blood cell indices were obtained with an electronic 
cell counter (Sysmex XE2100, Sysmex, Japan). Hemoglobin 
evaluation was carried out by electrophoresis on cellulose 
acetate at alkaline and neutral pHs, and the levels of Hb A2, 
Hb F, Hb H, and Hb Bart’s, when these were present, were 
quantified using cation exchange-high performance liquid 
chromatography (16) (Variant™, Bio-Rad Laboratories, 
USA). Preparations for the detection of Hb H inclusions 
were processed by incubating an aliquot of whole blood 
for 1 h at 37°C with 1% brilliant cresyl blue in buffered 
saline (16). 
Table 1. Demographic, hematological and molecular data for the patients and their families.
Cases P1 P2 P3 PM3 PB3 P4 P5 P6 P7 PF7 P8 PM8 PF8
Age/Gender 16/F 14/M 26/F 44/F 24/M 14/F 30/M 23/F 4m/F 29/M 3/M 27/M 30/M
RBC (106/mm3) 
(RF: M: 4.5-6.1, F: 4.2-5.4)
  5.02   4.86   4.66   5.05   5.38    5.03    5.97    5.64    5.35    6.15   6.09   4.55    6.37
Hb (g/L) 
(RF: M: 14-18, F: 12-16)
 9.4  9.2  7.7 11.3 14.5   9.0  10.6  11.5 10.3  13.3 11.3 13.3 13.9
MCV (fl) 
(RF: M: 81-99, F: 80-96)
62 66.5 68.2 80.4 89.2 66.2 59.4 61.7 60.4 67.6 58.3 89.5   67.8
MCH (pg) (RF: 27-32) 18.6 18.6 16.5 22.4 27 17.9 18.1 20.4 19.3 21.6 18.6 29.2    21.8
HbF (%) (RF: <1) 1.0 0.6 0.8 0.2 - 1.7 0.2 0.3 - 0.8 0.1 0.4      0.1
Hb A2 (%) (RF: 1.5-3.5) 1.3 1.2 1.5 2.7 - 1.6 1.5 2.6 - 3.1 3.0 3.4      3.0
Hb H (%) 4.5 13.4 9.5 - - 6.9 10.0 - - - - -   -
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Normal Normal Normal Normal Normal Normal
Sequencing of α-MRE Hapl A Hapl D Hapl A - - Hapl D Hapl D Hapl D Hapl A - Hapl A - -
P = patients; PM = patient’s mother; PB = patient’s brother; PF = patient’s father; RBC = red blood cells; Hb = hemoglobin; MCV = 
mean corpuscular volume; MCH = mean corpuscular hemoglobin; * by multiplex gap-PCR and/or specific PCR; Homo = homozygous; 
Hetero = heterozygous; Hapl = haplotype; RF = reference values; M = males; F = females; m = months. 
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Genomic DNA was extracted from peripheral blood 
samples collected in EDTA using a commercial kit (Blood 
GenomicPrep Mini-Spin, GE Healthcare, Amersham, UK). 
Patients in whom no abnormalities were found by multiplex 
gap-PCR for the common deletions [-α3.7, -α4.2, -(α)20.5, 
--MED, --SEA, --FIL, and -THAI] (14) were screened for com-
mon non-deletional mutations (HphI, NcoI and Tsaudi), after 
selective PCR amplification and restriction analysis (17). 
Direct nucleotide sequencing of the α-MRE was performed 
using primers described elsewhere (18) and an ABI 377 
DNA Analysis System (ABI PRISM™ 377 DNA Automated 
Sequencer, Applied BioSystems, USA).
The study was approved by the Ethics Committee 
(Opinion No. 918/2007, 18/02/2007) of the Universidade 
Estadual de Campinas and all subjects gave written in-
formed consent to participate.
MLPA reaction
A commercially available kit was used to screen for 
copy number variations involving the α-globin cluster on 
chromosome 16p13.3 (SALSA MLPA kit P140B2 HBA, 
MRC-Holland, The Netherlands). First, 26 probes included 
in the commercial kit were used, spanning a 130-kb region 
of the α-globin gene cluster from gene POLR3K (next to 
the tip of the short arm of chromosome 16) to the 3’ region 
of the α1-globin gene. HS-40 and all the coding genes (ζ, 
α2, and α1) were targeted (represented as darker arrows 
in Figure 1A). The probe mix included 12 reference probes 
targeting chromosomal sites other than those in the 16p13.3 
region, which were used as internal controls to normalize 
the results for each sample. Eighteen additional synthetic 
probes described elsewhere (15) were then synthesized 
to enlarge and refine map deletions and duplications dis-
tributed along an 800-kb genomic region from the POLR3K 
gene that can cause α-thalassemias. These oligonucle-
otides, synthesized in a salt-free environment (25-nmol 
scale), were from Invitrogen (USA) and were used without 
further purification. The MLPA reactions using these probes 
were carried out in two steps (represented as dotted and 
narrow arrows in Figure 1A). 
A 200- to 250-ng aliquot of DNA sample was used for 
each subject. Tests were performed with a standard ther-
mocycler (Eppendorf, Germany) according to manufacturer 
instructions. Amplification products were separated by 
capillary electrophoresis on a MegaBACE™ sequencer 
(GE Healthcare Life Sciences, Sweden) and the results 
were analyzed with Fragment Profiler® (MegaBACE™, 
GE Healthcare Life Science). At least three normal control 
samples were analyzed with each group of patient samples. 
Deletions previously confirmed by gap-PCR (-α3.7, -(α)20.5, 
--SEA, --MED, --FIL) were used as positive controls for the 
MLPA of the α-globin gene cluster. 
MLPA data analysis
Data from Fragment Profiler® were exported to Microsoft 
Excel for analysis. The relative probe signals were deter-
mined by dividing the peak height of each amplification 
product by the total peak height of the reference probes 
in the probe mix. Each normalized peak was then divided 
by the average height of the normalized peaks for normal 
control subjects. The upper threshold for deletions was set 
at 0.75, and the lower threshold for duplications at 1.25. 
Normal values were defined as being between 0.8 and 1.2. 
All samples were tested at least twice, and in some cases 
the same tests were carried out with samples from other 
members of the families. 
Results
In most diagnostic laboratories, a subset of thalassemia 
phenotypes for which no molecular defect has been identi-
fied by conventional techniques remains uncharacterized. 
However, thalassemia is still a possibility in these cases 
since the patients present persisting hematological altera-
tions such as hypochromia and microcytosis. We used MLPA 
to test DNA samples from eight patients whose hemato-
logical alterations could not be explained by conventional 
analysis of the globin genes. 
Five cases with Hb H (P1 to P5) were found to have 
a combination of the α0 deletion with the common α+3.7 
deletion, and 3 other patients were simple α0 heterozygous 
carriers (P6 to P8). Patient 1 (P1) showed a deletion limited 
to a region containing the upstream regulatory element HS-
40 (probes 2 and 3). Hence, although the α-globin genes 
were intact, they were not expressed in this patient. Three 
individuals (P2, P7, and P8) showed the same type of dele-
tion, in which the region from the telomere to the 5’ region 
of gene ζ encompassing probes 1 to 9 H (P2 and P7) and 
1 to 4 (P8) is absent. Large deletions involving the entire 
α-globin gene locus, including the α-MRE, were found in 
4 other cases (P3, P4, P5, and P6). These encompassed 
probes 1 to 22 H, 1 to 30 H (except 28 H), 1 to 30 H, and 
1 to 35 H, respectively. A schematic overview of all the 
deletions is shown in Figure 1A.
In the family analyses, the MLPA assay revealed that 
the mother and brother of patient 3 were homozygous and 
heterozygous, respectively, for the common -α3.7 deletion 
(probe 14α2 to 13α1), a result that is in agreement with the 
multiplex-PCR findings. Patients 7 and 8 had the same 
deletions as those detected in their parents (Figure 1B).
Discussion
α-Thalassemias are caused by a wide variety of molecu-
lar alterations, ranging from small deletions and/or insertions 
to very large deletions. This diversity of alterations is as-
sociated with the presence of several homologous regions, 
such as the Alu family of repeats, subsegments X, Y, and 
Z (between α-globin genes) and the GAGG motif, that are 
distributed along the α-locus and facilitate homologous and 
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Figure 1. Schematic representation of the short arm of chromosome 16 (16p13.3). A, An 800-kb region containing the α-globin gene cluster 
and HS-40 (adapted from Ref. 15). The oval shape denotes the telomeric repeat region, and the solid boxes denote the genes throughout 
the regions. The vertical arrows indicate the locations of the probe pairs; the different forms of arrows correspond to each group of probes: 
darker arrows represent probes included in the kit and dotted and narrow arrows correspond to synthetic probes. The bars below the figure 
indicate deletions found by multiplex ligation-dependent probe amplification (MLPA) in 8 patients (P). The vertical lines mark the first and 
last probes deleted. The open boxes indicate the region where deletion breakpoints are expected to be located. B, A 230-kb region contain-
ing the α-globin gene cluster and HS-40 (adapted from Ref. 15). The oval shape denotes the telomeric repeat region, and the solid boxes 
denote the genes throughout the regions. The vertical arrows show the locations of the probe pairs: the narrow arrows correspond to probes 
included in the kit, and the dotted arrow corresponds to synthetic probe 9H. Probes 13 and 16 included in the kit bind either gene α2 or α1. 
The bars below the figure indicate deletions found by MLPA in patient families; the vertical lines mark the first and last probes deleted. The 
open boxes mark the region where deletion breakpoints are expected to be located. M = mother; B = brother; F = father.
A
B
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non-homologous recombination events (19,20). Our results 
illustrate this diversity. The deletions found in this study are 
probably different from each other, and the breakpoints are 
probably unique because the deletions are rare and the 
patients were unrelated. As the MLPA method has been 
adapted for high-resolution mapping of deletions, we were 
able to investigate cases whose molecular alterations could 
not be identified by conventional techniques (multiplex gap-
PCR, specific PCR and DNA sequencing). 
Four of our patients (P1, P2, P7, and P8) had dele-
tions limited to a region containing the upstream regula-
tory element; hence, the α-globin genes, although intact, 
were not expressed. These deletions span a region of at 
least 0.4 kb in 1 case and from 95 to 100 kb in the others 
[positions 163464-163904, 97000-193847, 97000-202417, 
and 97000-202417 of the UCSC Genome Browser (21), 
February 2009, respectively]. Since the first description of 
a deletion of this type, which removes 62 kb including the 
HS-40 element (22), deletions involving this region have 
been described in more than 20 patients (10,15,23-31). The 
regulatory element α-MRE behaves as a classic enhancer: 
its main function in the normal chromosomal environment is 
to activate and enhance expression from the ζ-globin and 
α-globin promoters (32). Impairment of this element affects 
important binding sites for several transcriptional factors 
(GATA 1, NF-E2 and CACC box) and suppresses α-globin 
gene expression. Like the 
deletions that remove the 
α-globin genes, at least some 
of the α-MRE deletions seem 
to be the result of recombi-
nation events between par-
tially homologous Alu repeats 
and subtelomeric rearrange-
ments (2,20). 
Four other patients (P3, 
P4, P5, and P6) had large 
deletions spanning genomic 
regions of at least 240, 
470, 500, and 720 kb [posi-
tions 97000-334571, 97000-
570532, 97000-602492, and 
97000-816477 of the UCSC 
Genome Browser (21), Feb-
ruary 2009, respectively] 
that affect the entire α-globin 
gene cluster and its upstream 
regulatory element. In these 
cases, the deletions affected 
a considerable number of 
genes and could result in 
other clinical implications 
(e.g., mental retardation), 
as observed in ATR-16 syn-
dromes (33,34). However, no 
other abnormalities concomitant with α-thalassemia were 
reported in our patients. 
Although the exact breakpoint positions and deletion 
lengths could not be determined at the time of the study, 
the deletions found in 6 patients (P1, P2, P3, P6, P7, and 
P8) are close in terms of size and genome position to 
previously described alterations (10,24,26,27,31). Two 
deletions, found in patients 4 and 5, showed no resem-
blance to previously described deletions and are possibly 
novel. Different from other cases, the α0 deletion found in 
patient 4 may be the result of a breakage in the segment 
defined by probes 28 and 30 H, followed by inversion and 
deletion of the same segment. The binding site of probe 
28 H appears to be preserved since we obtained a normal 
peak signal for this probe, whereas for the other probes 
located in cis (27, 29, and 30 H) there was a reduction in 
peak signal (Figure 1A).
In the family analysis, MLPA assays for the mother and 
brother of patient 3 revealed an -α3.7 deletion in a homozy-
gous and heterozygous state, respectively. Since a sample 
from the patient’s father was not available, it was not possible 
to conclude whether the α0 deletion was inherited from the 
father or arose in the mother’s germ line. The same types 
of deletions found in patients 7 and 8 were found in their 
respective fathers, confirming the paternal origin of these 
mutations (Figures 1B and 2).
Figure 2. Pedigrees of the three families. A, The propositus (P3) had Hb H disease (α0 and -α3.7 
deletions), while her mother (P3M) and brother (P3B) were homozygous and heterozygous for the 
-α3.7 deletion, respectively. A sample from the father (P3F) was not available. B, The propositus 
(P7) and her father (P7F) were heterozygous for an α0 deletion. A sample from the mother (P7M) 
was not available. C, The propositus (P8) and his father (P8F) were heterozygous for an α0 dele-
tion, while his mother (P8M) was normal.
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